Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2006 1
2007 3
2008 2
2009 2
2010 2
2011 5
2012 2
2013 3
2014 2
2015 1
2016 3
2017 3
2019 6
2020 5
2021 6
2022 4
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer.
Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Kappeler C, Snapir A, Sarapohja T, Smith MR; ARAMIS Investigators. Fizazi K, et al. Among authors: jievaltas m. N Engl J Med. 2019 Mar 28;380(13):1235-1246. doi: 10.1056/NEJMoa1815671. Epub 2019 Feb 14. N Engl J Med. 2019. PMID: 30763142 Clinical Trial.
Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide.
Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Le Berre MA, Petrenciuc O, Snapir A, Sarapohja T, Smith MR; ARAMIS Investigators. Fizazi K, et al. Among authors: jievaltas m. N Engl J Med. 2020 Sep 10;383(11):1040-1049. doi: 10.1056/NEJMoa2001342. N Engl J Med. 2020. PMID: 32905676 Clinical Trial.
Efficacy and Safety of Darolutamide in Patients with Nonmetastatic Castration-resistant Prostate Cancer Stratified by Prostate-specific Antigen Doubling Time: Planned Subgroup Analysis of the Phase 3 ARAMIS Trial.
Bögemann M, Shore ND, Smith MR, Tammela TLJ, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Lebret T, Schostak M, Verholen F, Le Berre MA, Srinivasan S, Ortiz J, Mohamed AF, Sarapohja T, Fizazi K. Bögemann M, et al. Among authors: jievaltas m. Eur Urol. 2023 Mar;83(3):212-221. doi: 10.1016/j.eururo.2022.07.018. Epub 2022 Sep 9. Eur Urol. 2023. PMID: 36089529 Free article. Clinical Trial.
Association of gene polymorphisms with women urinary incontinence.
Aniulis P, Podlipskyte A, Smalinskiene A, Aniuliene R, Jievaltas M. Aniulis P, et al. Among authors: jievaltas m. Open Med (Wars). 2021 Aug 25;16(1):1190-1197. doi: 10.1515/med-2021-0332. eCollection 2021. Open Med (Wars). 2021. PMID: 34514165 Free PMC article.
Liproca Depot: A New Antiandrogen Treatment for Active Surveillance Patients.
Klotz L, Grudén S, Axén N, Gauffin C, Wassberg C, Bjartell A, Giddens J, Incze P, Jansz K, Jievaltas M, Rendon R, Richard PO, Ulys A, Tammela TL. Klotz L, et al. Among authors: jievaltas m. Eur Urol Focus. 2022 Jan;8(1):112-120. doi: 10.1016/j.euf.2021.02.003. Epub 2021 Feb 12. Eur Urol Focus. 2022. PMID: 33583762 Free article. Clinical Trial.
Short ischemia induces rat kidney mitochondria dysfunction.
Baniene R, Trumbeckas D, Kincius M, Pauziene N, Raudone L, Jievaltas M, Trumbeckaite S. Baniene R, et al. Among authors: jievaltas m. J Bioenerg Biomembr. 2016 Feb;48(1):77-85. doi: 10.1007/s10863-016-9643-2. Epub 2016 Jan 18. J Bioenerg Biomembr. 2016. PMID: 26782060
Primary Renal Angiosarcoma: Rare Tumour with Lethal Outcomes.
Venclovas Z, Alksnyte A, Rimsaite U, Navickis T, Jievaltas M, Milonas D. Venclovas Z, et al. Among authors: jievaltas m. Medicina (Kaunas). 2024 May 28;60(6):885. doi: 10.3390/medicina60060885. Medicina (Kaunas). 2024. PMID: 38929502 Free PMC article.
IMAGINE-IMpact Assessment of Guidelines Implementation and Education: The Next Frontier for Harmonising Urological Practice Across Europe by Improving Adherence to Guidelines.
Cornford P, Smith EJ, MacLennan S, Pereira-Azevedo N, Roobol MJ, Lumen N, Fullwood L, Duncan E, Dunsmore J, Plass K, Ribal MJ, Knoll T, Bjartell A, Van Poppel H, N'Dow J, Briganti A; Pan-European National Urological Society IMAGINE Collaborative. Cornford P, et al. Eur Urol. 2021 Feb;79(2):173-176. doi: 10.1016/j.eururo.2020.10.011. Epub 2020 Oct 29. Eur Urol. 2021. PMID: 33129581
Darolutamide and health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: An analysis of the phase III ARAMIS trial.
Smith MR, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Le Berre MA, Mohamed AF, Odom D, Bartsch J, Snapir A, Sarapohja T, Fizazi K. Smith MR, et al. Among authors: jievaltas m. Eur J Cancer. 2021 Sep;154:138-146. doi: 10.1016/j.ejca.2021.06.010. Epub 2021 Jul 14. Eur J Cancer. 2021. PMID: 34273811 Free article. Clinical Trial.
53 results